Flow Cytometry Reagents

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

245-NETWORK CONTRACT OFFICE 5 (36C245)

Contract Value

Not provided

Codes & Classification
Solicitation Number

36C24527Q0053

NAICS

325413 - In-Vitro Diagnostic Substance Manufacturing

Classification Code

6550

Additional Details
Set Aside

None

Place of Performance

Baltimore, Maryland, UNITED STATES

SourceSAM
Documents1
The Department of Veterans Affairs, through its Network Contract Office 5 (245-NETWORK CONTRACT OFFICE 5), has issued a Sources Sought notice (Procurement Identifier: 36C24527Q0053) seeking information from potential suppliers regarding the provision of flow cytometry reagents and related supplies. This request for information (RFI) is intended solely for planning and market research purposes and does not constitute a solicitation or a commitment to procure. Responses will inform the government’s acquisition strategy for a future procurement, but will not be considered as offers or proposals. **Purpose and Scope** The primary objective of this procurement is to support the Baltimore VA Medical Center’s Pathology and Laboratory Medicine Service, specifically the Hematology section, with all necessary reagents and supplies for flow cytometry testing. These materials are essential for conducting CD4/CD8 count testing and phenotyping white blood cells in leukemia and lymphoma assays, utilizing the Becton Dickinson FACSLyric flow cytometer. The reagents and supplies also include quality control (QC) and calibration materials, which are critical for monitoring cytometer settings, detecting voltages and spectral overlap, and ensuring optimal daily performance. **Key Requirements and Expected Deliverables** The notice provides a detailed list of required items, including various antibodies, staining solutions, buffers, calibration beads, and control materials. Each item is specified by brand name, part number, and estimated quantity. The reagents are primarily used for immunophenotyping and cell analysis, supporting diagnostic and research activities in hematology. Vendors are expected to provide products that meet or exceed the specifications of the listed brand name items, and may propose equivalent solutions or configurations. Any additional products that enhance the functionality of the identified product line are also welcome, provided they are clearly identified by brand name and part number. **Performance Period** The anticipated period of performance for this requirement is from December 3, 2026, to December 2, 2027. **Contracting Entity and Location** - Contracting Office: 245-NETWORK CONTRACT OFFICE 5 (36C245) - Department: Department of Veterans Affairs - Place of Performance: Baltimore, Maryland, United States **Classification Codes** - NAICS Code: 325413 (In-Vitro Diagnostic Substance Manufacturing, 2022) - Product Service Code: 6550 **Procurement Type and Special Considerations** This notice is a Sources Sought, not a solicitation. The government is seeking information on potential sources, product equivalency, and market capabilities. There are no set-aside requirements or contract type specified at this stage; these will be determined based on responses and further acquisition planning. Vendors are encouraged to submit descriptive literature demonstrating product equivalency, technical specifications, and any beneficial configurations. Additionally, respondents should provide company information, business size, manufacturer/distributor status, country of origin for all products, and an authorized distributor letter certified by the OEM with a current date. While not mandatory, a capabilities statement may also be submitted. **Constant Elements Over Contract Lifecycle** The requirement for high-quality, compatible flow cytometry reagents and supplies to support hematology testing at the Baltimore VA Medical Center will remain constant throughout the contract lifecycle. The need for QC and calibration materials to ensure reliable and accurate cytometer performance is also a core element. The procurement will continue to be governed by federal acquisition regulations and VA policies, with oversight from Network Contract Office 5. **Contact Information** - Primary Contact: Alison Klein - Email: [email protected] - Phone: 304-623-3461 x4143 **Response Instructions and Deadline** Interested vendors should respond by December 11, 2026, at 17:11. Responses should include all requested information and documentation as outlined in the notice. For further details and to access the official notice, visit: [SAM.gov Opportunity](https://sam.gov/opp/e0ec2015ab3d476d89e79a19ff794dac/view). This opportunity is ideal for manufacturers and authorized distributors of in-vitro diagnostic substances, particularly those with experience in supplying flow cytometry reagents and related laboratory materials to federal healthcare facilities. Vendors should carefully review the itemized requirements and ensure their products meet the technical and regulatory standards specified.